Vistagen Therapeutics, Inc. Common Stock (VTGN) is a publicly traded Healthcare sector company. As of May 21, 2026, VTGN trades at $0.64 with a market cap of $23.59M and a P/E ratio of -0.38. VTGN moved +1.22% today. Year to date, VTGN is -11.14%; over the trailing twelve months it is -75.67%. Its 52-week range spans $0.43 to $5.14. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces VTGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own VTGN include Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Vistagen Therapeutics, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $0.64 |
| Market Cap | $23.59M |
| P/E Ratio | -0.38 |
| EPS | $-1.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.14 |
| 52-Week Low | $0.43 |
| Volume | 822 |
| Avg Volume | 0 |
| Revenue (TTM) | $486.00K |
| Net Income | $-51.42M |
| Gross Margin | 0.00% |
1 analysts cover VTGN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.